Related Experiment Video
Updated: Jul 20, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Reevaluation of initial therapy: when is the appropriate time?
Stuart L Segelnick1, Mea A Weinberg
1Department of Periodontology and Implant Dentistry, New York University College of Dentistry, New York, NY, USA. eperiodr@aol.com
Determining the optimal time for periodontal reevaluation after initial therapy is crucial. Revisiting this evidence-based practice prevents overtreatment or disease progression, ensuring timely and appropriate patient care.
Area of Science:
- Dentistry
- Periodontology
Background:
- The timing for periodontal reevaluation following initial therapy is ambiguous and lacks consistent evidence-based guidelines.
- Current literature presents varied or absent timeframes for reevaluation, creating uncertainty among practitioners.
Purpose of the Study:
- To define periodontal reevaluation and establish an optimal time interval post-initial therapy.
- To address concerns regarding potential overtreatment with short reevaluation intervals or disease progression with prolonged intervals.
Main Methods:
- Review of classic and current periodontal literature.
- Analysis of expert opinions from periodontists.
- Discussion of the implications of different reevaluation timeframes.
Main Results:
- Inconsistent timeframes for periodontal reevaluation exist in the literature.
- Both premature and delayed reevaluation pose risks: overtreatment or disease progression, respectively.
Conclusions:
- A defined and evidence-based timeframe for periodontal reevaluation is necessary.
- The focus post-reevaluation should shift to periodontal stability rather than solely treatment effects.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Therapy
Antianxiety Medications
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Endocarditis III: Medical Management